References

Citations

1. American Psychiatric Association (2000). Anxiety disorders. In Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text rev., pp. 450–456. Washington, DC: American Psychiatric Association.

2. Raj BA, Sheehan DV (2001). Social anxiety disorder. Medical Clinics of North America, 85(3): 711–733.

3. Hales, RE, Yudofsky SC, eds. (2003). Social phobia. Textbook of Clinical Psychiatry, 4th ed., pp. 572–580. Washington, DC: American Psychiatric Publishing.

4. Stein MB, Kean YM (2000). Disability and quality of life in social phobia: Epidemiologic findings. American Journal of Psychiatry, 157(10): 1606–1613.

5. Van Ameringen MA, et al. (2001). Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study. American Journal of Psychiatry, 158(2): 275–281.

6. Wagstaff AJ, et al. (2002). Spotlight on paroxetine in psychiatric disorders in adults. Drugs, 62(4): 655–703.

7. U.S. Department of Health and Human Services (2008). 2008 Physical Activity Guidelines for Americans (ODPHP Publication No. U0036). Washington, DC: U.S. Government Printing Office. Available online: http://www.health.gov/paguidelines/pdf/paguide.pdf.

Other Works Consulted

• Zal HM (2003). Social phobia: Treatment issues. Psychiatric Times, 20(6): 80–83.

• Merikangas KR (2005). Anxiety disorders: Epidemiology. In BJ Sadock, VA Sadock, eds., Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 8th ed., vol. 1, pp. 1720–1728. Philadelphia: Lippincott Williams and Wilkins.

• Shear MK (2003). Anxiety disorders. In DC Dale, DD Federman, eds. Scientific American Medicine, section 13, chap. 8. New York: WebMD.